EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática

Inês Nalita D'avila de Lima Alencar, Ana Clara Ferreira Asbeque, Giovana Cristo de Oliveira Terças, Rita de Cássia Felipe de Lima, Amanda Vitória Rodrigues dos Santos, Sofia Elen Melania, Bianca Amorim Gonçalves, Elissandra Pereira Machado, Alan Patricio da Silva, Francisco Naildo Cardoso Leitão

Clinics Biopsychosocial · 2025

DOI: 10.54727/cbps.3.2.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics Biopsychosocial, 2025. Verfasst von Inês Nalita D'avila de Lima Alencar und 9 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mutations in the BRCA1 and BRCA2 genes play a crucial role in the development of breast and ovarian cancer in women, presenting significant implications for public health and prevention strategies. Late detection of these mutations can increase the risk of cancer, and the lack of knowledge about this genetic predisposition hinders the adoption of appropriate preventive measures.

Objective

To define the genetic and molecular characteristics associated with BRCA1 and BRCA2 mutations.

Method

Systematic review study without meta-analysis, following the gold standard protocol Preferential Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), using robust health sciences literature databases such as Pubmed, Lilacs, Virtual Health Library, and Scientific.

Results

The results show that the prevalence of BRCA mutations varies geographically, with 28.3% in Latin America and 33% in Northeast Brazil. More comprehensive genetic testing, such as those conducted in Hungary and Japan, has increased the detection of pathogenic variants. Moreover, research indicates an association between BRCA mutations and a higher incidence of triple-negative breast cancer in young women in Argentina. This geographical and ethnic variability reinforces the need for personalized strategies for diagnosis, prevention, and clinical management.

Conclusion

Research indicates that the prevalence of mutations in genes such as BRCA1/2 varies globally, influencing the risk of breast and ovarian cancer, and that precise identification of these mutations is essential for early detection and personalized treatment.

Zitieren

APA

Alencar, I. N. D. D. L., Asbeque, A. C. F., Terças, G. C. D. O., Lima, R. D. C. F. D., Santos, A. V. R. D., Melania, S. E., Gonçalves, B. A., Machado, E. P., Silva, A. P. D., & Leitão, F. N. C. (2025). Mutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática. Clinics Biopsychosocial. https://doi.org/10.54727/cbps.3.2.48

Vancouver

Alencar INDDL, Asbeque ACF, Terças GCDO, Lima RDCFD, Santos AVRD, Melania SE, et al. Mutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática. Clinics Biopsychosocial. 2025. doi:10.54727/cbps.3.2.48

BibTeX
@article{Alencar2025,
  author = {Alencar, Inês Nalita D'avila de Lima and Asbeque, Ana Clara Ferreira and Terças, Giovana Cristo de Oliveira and Lima, Rita de Cássia Felipe de and Santos, Amanda Vitória Rodrigues dos and Melania, Sofia Elen and Gonçalves, Bianca Amorim and Machado, Elissandra Pereira and Silva, Alan Patricio da and Leitão, Francisco Naildo Cardoso},
  title = {Mutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática},
  journal = {Clinics Biopsychosocial},
  year = {2025},
  doi = {10.54727/cbps.3.2.48}
}
Kostenlos starten →